Table 1 Demographic data and clinical characteristics of patients in the IVIG and non-IVIG groups
Parameter | Total n = 113 | Non-IVIG n = 66 | IVIG n = 47 | P |
|---|---|---|---|---|
Age | 55.1 ± 14.2 | 55.3 ± 15.5 | 54.8 ± 12.4 | 0.865 |
Female | 52 (46.0%) | 32 (48.5%) | 20 (42.6%) | 0.533 |
Comorbidity | 39 (34.5%) | 23 (34.8%) | 16 (34.0%) | 0.929 |
Hypertension | 26 (23.0%) | 14 (21.2%) | 12 (25.5%) | 0.591 |
Diabetes | 13 (11.5%) | 6 (9.1%) | 7 (14.9%) | 0.341 |
Coronary heart disease | 7 (6.2%) | 7 (10.6%) | 0 (0) | 0.021 |
COPD | 6 (5.3%) | 5 (7.6%) | 1 (2.1%) | 0.203 |
Cerebrovascular disease | 4 (3.5%) | 4 (6.1%) | 0 (0) | 0.086 |
Onset time | 7.0 (5.0–10.0) | 7.0 (5.0–9.2) | 7.0 (5.0–10.0) | 0.268 |
Maximum body temperature | 38.5 (37.8–39.0) | 38.0 (37.5–38.8) | 38.9 (38.2–39.0) | 0.002 |
WBC | 5.61 (4.09–8.04) | 5.00 (3.68–6.79) | 7.45 (4.73–9.42) | < 0.001 |
LYM | 1.07 (0.72–1.51) | 1.24 (0.90–1.75) | 0.79 (0.62–1.21) | < 0.001 |
PLT | 200.0 (153.0–256.0) | 203.0 (149.8–252.2) | 190.0 (159.0–257.0) | 0.836 |
ALT | 23.0 (16.5–37.2) | 21.0 (14.2–29.2) | 29.7 (18.0–47) | 0.008 |
AST | 21.0 (17.0–33.0) | 20.6 (16.8–26.2) | 22.0 (17.0–40.0) | 0.287 |
Cr | 78.1 ± 23.9 | 78.2 ± 24.3 | 78.8 ± 23.6 | 0.896 |
PT | 44.6 ± 1.3 | 11.4 ± 1.2 | 11.9 ± 1.4 | 0.56 |
DD | 192.0 (115.0–456.0) | 182.5 (105.8–294.5) | 216.0 (125.0–840.0) | 0.249 |
GC | 57 (50.4%) | 18 (27.3%) | 39 (83.0%) | < 0.001 |